Galmed Pharmaceuticals Ltd. (GLMD)
4.02
-0.28
(-6.62%)
USD |
NASDAQ |
Aug 24, 16:00
4.02
0.00 (0.00%)
After-Hours: 20:00
Galmed Pharmaceuticals Total Liabilities (Quarterly) : 2.079M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 2.079M |
| December 31, 2025 | 2.845M |
| September 30, 2025 | 2.472M |
| June 30, 2025 | 2.421M |
| March 31, 2025 | 1.807M |
| December 31, 2024 | 2.173M |
| September 30, 2024 | 2.514M |
| June 30, 2024 | 1.554M |
| March 31, 2024 | 1.765M |
| December 31, 2023 | 2.75M |
| September 30, 2023 | 2.091M |
| June 30, 2023 | 2.723M |
| March 31, 2023 | 2.801M |
| December 31, 2022 | 3.138M |
| September 30, 2022 | 5.12M |
| June 30, 2022 | 2.863M |
| March 31, 2022 | 5.83M |
| December 31, 2021 | 6.108M |
| September 30, 2021 | 6.622M |
| June 30, 2021 | 7.326M |
| March 31, 2021 | 7.42M |
| December 31, 2020 | 8.228M |
| September 30, 2020 | 6.297M |
| June 30, 2020 | 4.965M |
| March 31, 2020 | 6.335M |
| Date | Value |
|---|---|
| December 31, 2019 | 7.286M |
| September 30, 2019 | 3.929M |
| June 30, 2019 | 3.724M |
| March 31, 2019 | 2.908M |
| December 31, 2018 | 2.706M |
| September 30, 2018 | 2.139M |
| June 30, 2018 | 3.804M |
| March 31, 2018 | 2.698M |
| December 31, 2017 | 3.848M |
| September 30, 2017 | 3.145M |
| June 30, 2017 | 3.785M |
| March 31, 2017 | 4.356M |
| December 31, 2016 | 5.375M |
| September 30, 2016 | 3.934M |
| June 30, 2016 | 3.575M |
| March 31, 2016 | 3.201M |
| December 31, 2015 | 2.718M |
| September 30, 2015 | 1.513M |
| June 30, 2015 | 1.695M |
| March 31, 2015 | 1.561M |
| December 31, 2014 | 1.518M |
| September 30, 2014 | 2.933M |
| June 30, 2014 | 1.136M |
| March 31, 2014 | 1.928M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| BioLineRx Ltd. | 17.96M |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 113.60M |
| Can-Fite BioPharma Ltd. | -- |
| Revium Recovery, Inc. | 0.693M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 16.03M |
| Shareholders Equity (Quarterly) | 13.95M |
| Current Ratio | 7.709 |